Macmillan Cancer Support: Investment Portfolio & Startup News
Macmillan Cancer Support
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
52North raises £3.2m in funding led by Macmillan Cancer Support to support urgent cancer care diagnostics
52North is a medical technology spin-out from the University of Cambridge developing the Aster biomarker platform and Neutrocheck, a rapid finger-prick blood test. Neutrocheck supports remote triaging of chemotherapy patients at risk of neutropenic sepsis to reduce unnecessary emergency hospital visits.
Hypervision Surgical secures a £17m Series A led by Heal Capital to equip surgeons with next-gen tissue imaging
Hypervision Surgical develops imaging technology that provides real-time insights into tissue during surgery. Its platform enables surgeons to assess tissue physiology beyond what is visible to the human eye, supporting intraoperative decision-making.
Lucida Medical secures £8.7m in funding led by IW Capital to detect early prostate cancer in scans with AI
Lucida Medical develops software to help clinicians detect prostate cancer from MRI scans. It analyses scans to highlight suspicious areas and support faster and more consistent diagnostic decisions.
Infinitopes secures an £11m seed round led by Octopus Ventures and Amplify Bio to prevent recurrence of oesophageal cancer
Infinitopes develops off-the-shelf precision cancer vaccines designed to prevent recurrence, using AI-powered immunomics to target shared tumour features and advance new immunotherapies into clinical trials.
Perci Health secures £3m from UK venture funds and Macmillan Cancer Support to scale virtual cancer clinic
Perci Health runs a virtual cancer clinic that combines digital tools with multidisciplinary specialist care, supporting patients through treatment, recovery and survivorship while addressing gaps in long-term cancer care provision.
Oncology medical tech startup 52North secures £5m with landmark UK-US hospital VC deal
52North builds medical devices and digital tools that support cancer patients outside hospital, focusing on early detection and monitoring of treatment-related complications to improve urgent oncology care pathways.
- 4(12 months)
- Update Information
More venture news
- 26 Oct 2026
NousNous raises £13m in funding led by Heartcore Capital and Mosaic Ventures for an AI agent that manages household bills and admin
EquityConsumer - 19 Oct 2026
FrugaFruga secures a £1m in funding led by PXN Ventures to lower insurance renewal premiums through open banking
EquityFintech - 13 Oct 2026
SainapticSainaptic raises £1m in funding led by Cornerstone VC and Ufi Ventures for AI-assisted marking of vocational and professional qualifications
EquityEducation
